肾炎康复片联合常规西药治疗慢性肾衰竭临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R692.5

基金项目:


Clinical Study on Shenyan Kangfu Tablets Combined with Conventional Western Medicine for Chronic Renal Failure
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察肾炎康复片联合常规西药治疗慢性肾衰竭的临床疗效及其对肾功能、血清炎性因子的 影响。方法:选取慢性肾衰竭患者100 例,按随机数字表法分为对照组和观察组各50 例。对照组给予西药常 规治疗,观察组在对照组基础上予以肾炎康复片治疗,共治疗8 周。比较2 组治疗前后肾功能、血清炎性因子 水平,并评价2 组临床疗效,观察不良反应以及转归情况。结果:观察组总有效率为92.00%,高于对照组 78.00% (P<0.05)。与治疗前比较,治疗后2 组血肌酐(SCr)、尿素氮(BUN) 及24 小时尿蛋白(24 hUp) 水平降低,肾小球滤过率(GFR) 升高(P<0.05);观察组SCr、BUN 及24 h Up 水平低于对照组,GFR 高于 对照组(P<0.05)。与治疗前比较,治疗后2 组血清白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α) 水平 降低(P<0.05),且观察组血清IL-6、TNF-α 水平低于对照组(P<0.05)。治疗后12 个月,观察组疾病减轻 率为16.00%,高于对照组的4.00%(P<0.05)。观察组疾病进展率为8.00%,低于对照组24.00%(P<0.05)。 结论:肾炎康复片联合西医常规治疗可提高慢性肾衰竭的临床疗效,延缓肾功能下降和疾病进程,并降低血清 炎性因子水平,减轻机体炎症反应。

    Abstract:

    Abstract:Objective:To observe the clinical effect of the therapy of Shenyan Kangfu Tablets combined with conventional western medicine on chronic renal failure and its influence on renal function and serum inflammatory factors. Methods:A total of 100 patients with chronic renal failure were randomly divided into the control group and the observation group,with 50 cases in each group. The control group was treated with conventional western medicine, and the observation group was additionally treated with Shenyan Kangfu Tablets based on the treatment of the control group,for a total of eight weeks. The levels of renal function and serum inflammatory factors were compared between the two groups before and after treatment, and the clinical effects, adverse reactions and outcomes were evaluated. Results: The total effective rate was 92.00% in the observation group,higher than that of 78.00% in the control group(P< 0.05). After treatment,the levels of serum creatinine(SCr),urea nitrogen(BUN) and 24-hour urinary protein (24hUp) in the two groups were decreased when compared with those before treatment, and the glomerular filtration rate(GFR) was respectively increased(P<0.05);the levels of SCr,BUN and 24h Up in the observation group were lower than those in the control group,and the GFR level was higher(P<0.05). After treatment,the levels of serum interleukin- 6(IL- 6) and tumor necrosis factor- α(TNF- α) in the two groups were decreased when compared with those before treatment(P<0.05), and the levels of serum IL- 6 and TNF- α in the observation group were lower than those in the control group(P<0.05). Twelve months after treatment,the remission rate of disease in the observation group was 16.00%,higher than that of 4.00% in the control group(P<0.05). The progression rate of disease in the observation group was 8.00% , lower than that of 24.00% in the control group(P<0.05). Conclusion: The therapy of Shenyan Kangfu Tablets combined with conventional western medicine can improve the clinical effect of chronic renal failure, delay the decline of renal function and disease process, reduce the levels of serum inflammatory factors,and reduce the body's inflammatory responses.

    参考文献
    相似文献
    引证文献
引用本文

陈茜芸,曾慧莲,周颖,柳磊.肾炎康复片联合常规西药治疗慢性肾衰竭临床研究[J].新中医,2023,55(1):96-99

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-01-17
  • 出版日期:
文章二维码